Director & Consultant PediatricsView Profile
Consultant Physician & CardiologistView Profile
M.S. SurgeonView Profile
In Charge Path. Lab.View Profile
Senior Consultant & Head of Obst. & GyaneView Profile
Immunotherapy has the potential to reduce the risk of heart disease in patients suffering with rheumatoid arthritis, finds a study. tag heuer replica watches
Rheumatoid arthritis is an autoimmune disease in which cytokines such as tumour necrosis factor-alpha (TNFI) and interfero-gamma (IFN), which normally protect the body, attack healthy cells
The findings showed that the combination of two anticytokines containing extra-low doses of antibodies against TNFI and IFN could improve the efficacy of standard rheumatoid arthritis therapy and decrease heart disease risk.
“In rheumatoid arthritis, patients have painful and inflamed joints. They are also at increased cardiovascular risk, particularly if their rheumatoid arthritis is not controlled,” said Aida Babaeva, Professor at Volgograd State Medical University in Russia.